Occupational and Biomass Exposure in Chronic Obstructive Pulmonary Disease: Results of a Cross-Sectional Analysis of the On-Sint Study

被引:11
|
作者
Luis Lopez-Campos, Jose [1 ,2 ]
Fernandez-Villar, Alberto [3 ]
Calero-Acuna, Carmen [1 ]
Represas-Represas, Cristina [3 ]
Lopez-Ramirez, Cecilia [1 ]
Leiro Fernandez, Virginia [3 ]
Casamor, Ricard [4 ]
机构
[1] Univ Seville, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBiS, Unidad Med Quirurg Enfermedades Resp, Seville, Spain
[2] Inst Salud Carlos III, CIBER Enfermedades Resp CIBERES, Madrid, Spain
[3] Complexo Hosp Vigo, Inst Invest Biomed Vigo IBIV, Serv Neumol, Vigo, Pontevedra, Spain
[4] Novartis Farmaceut, Dept Med, Barcelona, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2017年 / 53卷 / 01期
关键词
Chronic obstructive pulmonary disease; Biomass; Occupational; Epidemiology; Geographic distribution; CHRONIC-BRONCHITIS; RESPIRATORY SYMPTOMS; LONGITUDINAL CHANGES; AIR-POLLUTION; COPD; SMOKE; COHORT; RISK; POPULATION; TOBACCO;
D O I
10.1016/j.arbres.2016.04.013
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Although tobacco smoke is the main risk factor for chronic obstructive pulmonary disease (COPD), other inhaled toxics have also been associated with the disease. The present study analyzes data from exposure to these substances in a cohort of patients with COPD and assesses their impact on the clinical presentation of the disease. Methods: This is a cross-sectional analysis of the Clinical presentation, diagnosis and course of chronic obstructive pulmonary disease (On-Sint) study. All patients were smokers or ex-smokers as per protocol. In addition, during the inclusion visit patients were enquired about their occupational and biomass exposure history. The clinical features of patients with and without an added risk factor to tobacco were compared and those significant were entered in a multivariate logistic regression analysis, expressed as odds ratio (OR). Results: The sample size was 1214 patients with COPD, of which 1012 (83.4%) had tobacco as the only risk factor and 202 (16.6%) had additional ones, mainly 174 (14.3%) with occupational gases and 32 (2.6%) with biomass exposure. The geographical distribution of this exposure showed a preference for the northern parts of the country and the East coast. The biomass exposure was rather low. Male gender (OR: 2.180), CAT score (OR: 1.036) and the use of long-term oxygen therapy (OR: 1.642) were associated with having an additional risk factor in the multivariate analysis. Conclusions: Occupational exposures are more common than biomass in Spain. COPD caused by tobacco plus other inhalants has some differential features and a more impaired quality of life. (C) 2016 SEPAR. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [1] Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
    Barrera, Lucia Marin
    Ramirez, Cecilia Lopez
    Lopez-Campos, Jose Luis
    Acuna, Carmen Calero
    Fernandez-Villar, Alberto
    Represas, Cristina Represas
    Carrera, Ana Priegue
    Casamor, Ricard
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [2] Prevalence of osteoarthritis in Korean patients with chronic obstructive pulmonary disease: a cross-sectional study
    Jung, Jae Hyun
    Lim, Ji Hyun
    Seok, Hongdeok
    Song, Gwan Gyu
    Choi, Sung Jae
    KUWAIT MEDICAL JOURNAL, 2023, 55 (04): : 336 - 342
  • [3] Assessment of lung hyperinflation in occupational chronic obstructive pulmonary disease: a multicentric cross-sectional study
    de Broucker, Virginie
    Andujar, Pascal
    Wardyn, Pierre-Marie
    Lepage, Nadege
    Le Rouzic, Olivier
    Edme, Jean-Louis
    Hulo, Sebastien
    BMJ OPEN RESPIRATORY RESEARCH, 2023, 10 (01)
  • [4] Occupational exposure and risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis
    Alif, Sheikh M.
    Dharmage, Shyamali C.
    Bowatte, Gayan
    Karahalios, Amalia
    Benke, Geza
    Dennekamp, Martine
    Mehta, Amar J.
    Miedinger, David
    Kuenzli, Nino
    Probst-Hensch, Nicole
    Matheson, Melanie C.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (08) : 861 - 872
  • [5] Characteristics of Patients with Chronic Obstructive Pulmonary Disease Exposed to Different Environmental Risk Factors: A Large Cross-Sectional Study
    Duan, Jia-xi
    Cheng, Wei
    Zeng, Yu-qin
    Chen, Yan
    Cai, Shan
    Li, Xin
    Zhu, Ying-qun
    Chen, Ming
    Zhou, Mei-ling
    Ma, Li-bing
    Liu, Qi-mi
    Chen, Ping
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2857 - 2867
  • [6] Sex Hormones and Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study and Mendelian Randomization Analysis
    Du, Dongru
    Ran, Bi
    Xu, Dan
    Liu, Lian
    Hu, Xueru
    Zeng, Tingting
    Shen, Yongchun
    Luo, Fengming
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 1649 - 1660
  • [7] Obstructive sleep apnea, chronic obstructive pulmonary disease and hypertensive microvascular disease: a cross-sectional observational cohort study
    Chew, Sky
    Colville, Deb
    Hutchinson, Anastasia
    Canty, Piers
    Hodgson, Lauren
    Savige, Judy
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [8] A cross-sectional analysis of diagnosis and management of chronic obstructive pulmonary disease in people living with HIV Opportunities for improvement
    Zifodya, Jerry S.
    Triplette, Matthew
    Shahrir, Shahida
    Attia, Engi F.
    Akgun, Kathleen M.
    Hoo, Grant W. Soo
    Rodriguez-Barradas, Maria C.
    Wongtrakool, Cherry
    Huang, Laurence
    Crothers, Kristina
    MEDICINE, 2021, 100 (37)
  • [9] Relationship of perfluoroalkyl chemicals with chronic obstructive pulmonary disease: A cross-sectional study
    Li, Xuefang
    Li, Zhijun
    Ye, Jian
    Ye, Wu
    TOXICOLOGY AND INDUSTRIAL HEALTH, 2025, 41 (03) : 176 - 185
  • [10] Association Between Urinary Phthalate Metabolites and Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study
    Li, Xuefang
    Li, Zhijun
    Ye, Jian
    Ye, Wu
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 1421 - 1431